Sartorius Stedim Biotech Statistics

Total Valuation

FRA:56S1 has a market cap or net worth of EUR 19.59 billion. The enterprise value is 21.85 billion.

Market Cap	19.59B
Enterprise Value	21.85B

Important Dates

The next estimated earnings date is Tuesday, July 22, 2025.

Earnings Date	Jul 22, 2025
Ex-Dividend Date	Apr 2, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+3.64%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.74M

Valuation Ratios

The trailing PE ratio is 95.87.

PE Ratio	95.87
Forward PE	n/a
PS Ratio	6.85
PB Ratio	4.89
P/TBV Ratio	n/a
P/FCF Ratio	33.56
P/OCF Ratio	22.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 31.89, with an EV/FCF ratio of 37.44.

EV / Earnings	106.94
EV / Sales	7.65
EV / EBITDA	31.89
EV / EBIT	52.24
EV / FCF	37.44

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.73.

Current Ratio	1.85
Quick Ratio	1.04
Debt / Equity	0.73
Debt / EBITDA	4.23
Debt / FCF	5.03
Interest Coverage	2.62

Financial Efficiency

Return on equity (ROE) is 5.25% and return on invested capital (ROIC) is 3.81%.

Return on Equity (ROE)	5.25%
Return on Assets (ROA)	3.19%
Return on Invested Capital (ROIC)	3.81%
Return on Capital Employed (ROCE)	5.82%
Revenue Per Employee	286,889
Profits Per Employee	20,510
Employee Count	9,901
Asset Turnover	0.34
Inventory Turnover	2.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.90%
50-Day Moving Average	190.92
200-Day Moving Average	185.33
Relative Strength Index (RSI)	58.08
Average Volume (20 Days)	19

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:56S1 had revenue of EUR 2.86 billion and earned 204.30 million in profits. Earnings per share was 2.11.

Revenue	2.86B
Gross Profit	1.25B
Operating Income	426.80M
Pretax Income	257.20M
Net Income	204.30M
EBITDA	667.50M
EBIT	426.80M
Earnings Per Share (EPS)	2.11

Full Income Statement

Balance Sheet

The company has 707.60 million in cash and 2.93 billion in debt, giving a net cash position of -2.23 billion.

Cash & Cash Equivalents	707.60M
Total Debt	2.93B
Net Cash	-2.23B
Net Cash Per Share	n/a
Equity (Book Value)	4.01B
Book Value Per Share	40.84
Working Capital	815.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 879.50 million and capital expenditures -295.90 million, giving a free cash flow of 583.60 million.

Operating Cash Flow	879.50M
Capital Expenditures	-295.90M
Free Cash Flow	583.60M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.89%, with operating and profit margins of 14.94% and 7.15%.

Gross Margin	43.89%
Operating Margin	14.94%
Pretax Margin	9.00%
Profit Margin	7.15%
EBITDA Margin	23.36%
EBIT Margin	14.94%
FCF Margin	20.42%

Dividends & Yields

This stock pays an annual dividend of 0.69, which amounts to a dividend yield of 0.36%.

Dividend Per Share	0.69
Dividend Yield	0.36%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	32.84%
Buyback Yield	-3.64%
Shareholder Yield	-3.28%
Earnings Yield	1.04%
FCF Yield	2.98%

Dividend Details

Stock Splits

The last stock split was on May 6, 2016. It was a forward split with a ratio of 6.

Last Split Date	May 6, 2016
Split Type	Forward
Split Ratio	6

Scores

FRA:56S1 has an Altman Z-Score of 3.64.

Altman Z-Score	3.64
Piotroski F-Score	n/a